Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric lipase is an acidic lipase encoded by the LIPF gene, secreted by gastric chief cells. It functions optimally at pH 3-6 and hydrolyzes triglyceride ester bonds, initiating dietary fat digestion in the stomach and continuing in the duodenum. It forms part of the acid lipase gene family and features a catalytic triad but does not require cofactors like pancreatic lipase. Gastric lipase is crucial for fat digestion in infants and becomes particularly important when pancreatic function is impaired. Low levels are associated with gastric cancer. Unlike pancreatic lipase, it doesn't require bile acid or colipase, making it effective in acidic environments. Its activity can be inhibited by drugs like Orlistat.
Orlistat interferes with the activity of lipase enzymes by blocking them from breaking down fats, preventing fat absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric lipase.